Close Menu


Exact Sciences gains exclusive, worldwide rights to DNA methylation markers, which will be used in the firm's colorectal cancer test.

The certification was for the firm's lab in Belgium.

OncoMethylome's grant revenues were down for the quarter, but were offset by an increase in commercial sales.

Pairings: Apr 14, 2010


Jan Groen

In reporting its half-year 2009 financial results last month, OncoMethylome Sciences disclosed that it has inked new partnerships with pharmaceutical companies to discover cancer biomarkers for companion diagnostic development, and is providing companion diagnostic testing services for two clinical trials on personalizing glioblastoma treatments.

The firm's revenues fell year over year due to non-recurring fees it received in 2008.


The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.